相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis
Tonisha Kearney-Ramos et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Cannabis is associated with blood pressure reduction in older adults-A 24-hours ambulatory blood pressure monitoring study
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities
Adam I. Perlman et al.
MAYO CLINIC PROCEEDINGS (2021)
Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption
Shelly Tartakover Matalon et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Cannabis and its derivatives for the use of motor symptoms in Parkinson's disease: a systematic review and meta-analysis
Susan J. Thanabalasingam et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
The longitudinal relationship between cannabis use and hypertension
Ahmed Haleem et al.
DRUG AND ALCOHOL REVIEW (2021)
The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
Salahaden R. Sultan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
Patryk Remiszewski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study
Lea Tischmann et al.
NUTRIENTS (2020)
Endocannabinoid levels in patients with Parkinson's disease with and without levodopa-induced dyskinesias
Camila Marchioni et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Circulating Endocannabinoids and Mortality in Hemodialysis Patients
Hamid Moradi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2020)
Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans
Shahar Azar et al.
OBESITY SURGERY (2019)
Lower circulating endocannabinoid levels in children with autism spectrum disorder
Adi Aran et al.
MOLECULAR AUTISM (2019)
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus
Alain Veilleux et al.
CURRENT DIABETES REPORTS (2019)
Cannabis effects on lipoproteins
Julieta Lazarte et al.
CURRENT OPINION IN LIPIDOLOGY (2019)
A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis
Maya R. Jacobson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
Hamid Moradi et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Serum Levels of Endocannabinoids are Independently Associated with Nonalcoholic Fatty Liver Disease
Shira Zelber-Sagi et al.
OBESITY (2017)
MECHANISMS IN ENDOCRINOLOGY Endocannabinoids and metabolism: past, present and future
Vincent Simon et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada
Hayley A. Hamilton et al.
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE (2017)
Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review
Ji-Yeun Park et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
Khalid A. Jadoon et al.
JCI INSIGHT (2017)
Trends in registered medical marijuana participation across 13 US states and District of Columbia
Brian J. Fairman
DRUG AND ALCOHOL DEPENDENCE (2016)
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
Geke A. H. van den Elsen et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
Wilfrid Mazier et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans
Ulrike Thieme et al.
DRUG TESTING AND ANALYSIS (2014)
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
Amir I. A. Ahmed et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Metabolic Effects of Chronic Cannabis Smoking
Ranganath Muniyappa et al.
DIABETES CARE (2013)
Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans
Carmen Walter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity
Isabelle Matias et al.
PLOS ONE (2012)
Increased Blood Pressure After Abrupt Cessation of Daily Cannabis Use
Ryan Vandrey et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
分享论文
